Clostridium Infections
"Clostridium Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Infections with bacteria of the genus CLOSTRIDIUM.
Descriptor ID |
D003015
|
MeSH Number(s) |
C01.252.410.222
|
Concept/Terms |
Clostridium Infections- Clostridium Infections
- Infections, Clostridium
- Clostridium Infection
- Infection, Clostridium
|
Below are MeSH descriptors whose meaning is more general than "Clostridium Infections".
Below are MeSH descriptors whose meaning is more specific than "Clostridium Infections".
This graph shows the total number of publications written about "Clostridium Infections" by people in UAMS Profiles by year, and whether "Clostridium Infections" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2023 | 1 | 0 | 1 | 2022 | 1 | 0 | 1 | 2021 | 2 | 0 | 2 | 2020 | 4 | 0 | 4 | 2019 | 4 | 0 | 4 | 2018 | 1 | 1 | 2 | 2017 | 6 | 0 | 6 | 2015 | 2 | 0 | 2 | 2014 | 2 | 0 | 2 | 2013 | 3 | 0 | 3 | 2012 | 1 | 0 | 1 | 2011 | 2 | 0 | 2 | 2010 | 1 | 0 | 1 | 2008 | 0 | 1 | 1 | 1996 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Clostridium Infections" by people in Profiles over the past ten years.
-
Oliva-Hemker M, Kahn SA, Steinbach WJ. Fecal Microbiota Transplantation: Information for the Pediatrician. Pediatrics. 2023 Dec 01; 152(6).
-
Khadem TM, Nguyen MH, Bariola JR. Evaluation of fidaxomicin use in community hospitals after a clinical guideline change at a large health system and opportunities for stewardship. Infect Control Hosp Epidemiol. 2023 02; 44(2):312-314.
-
Gupta S, Zhu J, McCarty TR, Pruce J, Kassam Z, Kelly C, Fischer M, Allegretti JR. Cost-effectiveness analysis of sequential fecal microbiota transplantation for fulminant Clostridioides difficile infection. J Gastroenterol Hepatol. 2021 Sep; 36(9):2432-2440.
-
Redding L, Huang E, Ryave J, Webb T, Barnhart D, Baker L, Bender J, Kristula M, Kelly D. Clostridioides difficile on dairy farms and potential risk to dairy farm workers. Anaerobe. 2021 Jun; 69:102353.
-
Chen X, Yang X, de Anda J, Huang J, Li D, Xu H, Shields KS, D?unkov? M, Hansen J, Patel IJ, Yee EU, Golenbock DT, Grant MA, Wong GCL, Kelly CP. Clostridioides difficile Toxin A Remodels Membranes and Mediates DNA Entry Into Cells to Activate Toll-Like Receptor 9 Signaling. Gastroenterology. 2020 12; 159(6):2181-2192.e1.
-
McCarson KL, Walters CA, Cantu RM. Unusual Cause of Sepsis in a 10-Year-Old Female. Clin Pediatr (Phila). 2020 10; 59(11):1036-1039.
-
Mayer EF, Maron G, Dallas RH, Ferrolino J, Tang L, Sun Y, Danziger-Isakov L, Paulsen GC, Fisher BT, Vora SB, Englund J, Steinbach WJ, Michaels M, Green M, Yeganeh N, Gibson JE, Dominguez SR, Nicholson MR, Dulek DE, Ardura MI, Rajan S, Gonzalez BE, Beneri C, Herold BC. A multicenter study to define the epidemiology and outcomes of Clostridioides difficile infection in pediatric hematopoietic cell and solid organ transplant recipients. Am J Transplant. 2020 08; 20(8):2133-2142.
-
Shah KJ, Cherabuddi K, Pressly KB, Wright KL, Shukla A. Clostridioides difficile associated peritonitis in peritoneal dialysis patients - a case series based review of an under-recognized entity with therapeutic challenges. BMC Nephrol. 2020 03 04; 21(1):76.
-
Zhang Y, Shaikh N, Ferey JL, Wankhade UD, Chintapalli SV, Higgins CB, Crowley JR, Heitmeier MR, Stothard AI, Mihi B, Good M, Higashiyama T, Swarts BM, Hruz PW, Shankar K, Tarr PI, DeBosch BJ. Lactotrehalose, an Analog of Trehalose, Increases Energy Metabolism Without Promoting Clostridioides difficile Infection in Mice. Gastroenterology. 2020 04; 158(5):1402-1416.e2.
-
Juretschko S, Manji R, Khare R, Das S, Dunbar S. Performance Evaluation of the Luminex Aries C. difficile Assay in Comparison to Two Other Molecular Assays within a Multihospital Health Care Center. J Clin Microbiol. 2019 11; 57(11).
-
Smith AD, Foss ED, Zhang I, Hastie JL, Giordano NP, Gasparyan L, VinhNguyen LP, Schubert AM, Prasad D, McMichael HL, Sun J, Beger RD, Simonyan V, Cowley SC, Carlson PE. Microbiota of MR1 deficient mice confer resistance against Clostridium difficile infection. PLoS One. 2019; 14(9):e0223025.
-
Ahmed J, Kumar A, Jafri F, Batool S, Knoll B, Lim SH. Low Incidence of Hospital-Onset Clostridium difficile Infection in Sickle Cell Disease. N Engl J Med. 2019 02 28; 380(9):887-888.
-
Apewokin S, Lee JY, Goodwin JA, McKelvey KD, Stephens OW, Zhou D, Coleman EA. Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study. Support Care Cancer. 2018 Sep; 26(9):3127-3134.
-
Cabal A, Jun SR, Jenjaroenpun P, Wanchai V, Nookaew I, Wongsurawat T, Burgess MJ, Kothari A, Wassenaar TM, Ussery DW. Genome-Based Comparison of Clostridioides difficile: Average Amino Acid Identity Analysis of Core Genomes. Microb Ecol. 2018 Oct; 76(3):801-813.
-
Chatterjee K, Goyal A, Chada A, Kakkera KS, Corwin HL. National Trends (2007-2013) of Clostridium difficile Infection in Patients with Septic Shock: Impact on Outcome. J Hosp Med. 2017 09; 12(9):717-722.
-
Goyal A, Chatterjee K, Yadlapati S, Rangaswami J. Impact of end stage kidney disease on costs and outcomes of Clostridium difficile infection. Int J Infect Dis. 2017 Sep; 62:8-9.
-
Goyal A, Chatterjee K, Punjabi C, Rangaswami J. Thirty-Day Readmissions After Hospitalization for Clostridium difficile Enteritis Measures and Predictors: A Nationwide Analysis. Infect Control Hosp Epidemiol. 2017 07; 38(7):876-878.
-
Kent M, Over DR. Clostridium Perfringens Sepsis With Massive Intravascular Hemolysis. J Ark Med Soc. 2017 Mar; 113(9):212-214.
-
Vargas E, Apewokin S, Madan R. Role of the leukocyte response in normal and immunocompromised host after Clostridium difficile infection. Anaerobe. 2017 Jun; 45:101-105.
-
Anand R, Song Y, Garg S, Girotra M, Sinha A, Sivaraman A, Phillips L, Dutta SK. Effect of Aging on the Composition of Fecal Microbiota in Donors for FMT and Its Impact on Clinical Outcomes. Dig Dis Sci. 2017 04; 62(4):1002-1008.
-
Costello SP, Tucker EC, La Brooy J, Schoeman MN, Andrews JM. Establishing a Fecal Microbiota Transplant Service for the Treatment of Clostridium difficile Infection. Clin Infect Dis. 2016 Apr 01; 62(7):908-14.
-
Apewokin S, Goodwin JA, Lee JY, Erickson SW, Sanathkumar N, Raj VR, Zhou D, McKelvey KD, Stephens O, Coleman EA. Contribution of Clostridium difficile infection to the development of lower gastrointestinal adverse events during autologous stem cell transplantation. Transpl Infect Dis. 2015 Aug; 17(4):566-73.
|
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|